• HELP
  • FAQs
  • INTRANET

Uganda Virus Research Institute

REPUBLIC OF UGANDA

News Updates

ISARIC/ALERRT Clinical Characterisation Protocol (CCP) observational study

In an effort to contribute to the global research efforts into COVID-19, a team based at Uganda Virus Research Institute (UVRI), Uganda, is participating in the ISARIC/ALERRT Clinical Characterisation Protocol (CCP) observational study. This protocol seeks to support a rapid, coordinated clinical investigation of confirmed cases of COVID-19.

Pages